Related references
Note: Only part of the references are listed.Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study
Scott Fung et al.
JOURNAL OF HEPATOLOGY (2017)
Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients
Kavita Radhakrishnan et al.
TRANSPLANTATION (2017)
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro
Romina Salpini et al.
ONCOTARGET (2017)
Adverse effects of oral antiviral therapy in chronic hepatitis B
Bircan Kayaaslan et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany
Joerg Petersen et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Systematic review with meta-analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance
F. Liu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients
P. Lampertico et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France
Patrick Marcellin et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Nucleos(t)ide analogues causes HBV S gene mutations and carcinogenesis
Meng-Lan Wang et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2016)
EASL Clinical Practice Guidelines: Liver transplantation
Patrizia Burra et al.
JOURNAL OF HEPATOLOGY (2016)
Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin
Bruno Roche et al.
TRANSPLANTATION (2015)
Effect of serum hepatitis B surface antigen levels on predicting the clinical outcomes of chronic hepatitis B infection: A meta-analysis
Li-Shuai Qu et al.
HEPATOLOGY RESEARCH (2015)
Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
Peijie Wang et al.
PLOS ONE (2014)
Safety and Efficacy of Subcutaneous Hepatitis B Immunoglobulin After Liver Transplantation: An Open Single-Arm Prospective Study
G. G. Di Costanzo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review
E. Cholongitas et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Adherence to Medication Is a More Important Contributor to Viral Breakthrough in Chronic Hepatitis B Patients Treated with Entecavir Than in Those with Lamivudine
Hidehiro Kamezaki et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
Liver transplantation for HBV-related cirrhosis in Europe: An ELTR study on evolution and outcomes
Patrizia Burra et al.
JOURNAL OF HEPATOLOGY (2013)
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigenpositive liver transplant candidates
Edward J. Gane et al.
LIVER TRANSPLANTATION (2013)
Adherence to nucleos(t)ide analogues for chronic hepatitis B in clinical practice and correlation with virological breakthroughs
W. Chotiyaputta et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Hepatitis B Virus Large Surface Antigen Promotes Liver Carcinogenesis by Activating the Src/PI3K/Akt Pathway
Haiou Liu et al.
CANCER RESEARCH (2011)
Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation
James Fung et al.
GASTROENTEROLOGY (2011)
Efficacy and safety of subcutaneous human HBV-immunoglobulin (Zutectra®) in liver transplantation: an open, prospective, single-arm phase III study
Ali Yahyazadeh et al.
TRANSPLANT INTERNATIONAL (2011)
Drug Therapy: Tenofovir
Anna S. Lok
HEPATOLOGY (2010)
Outcomes of Long-Term Administration of Intravenous Hepatitis B Immunoglobulins for the Prevention of Recurrent Hepatitis B After Liver Transplantation
K. Pauwelyn et al.
TRANSPLANTATION PROCEEDINGS (2010)
Side Effects of Long-Term Oral Antiviral Therapy for Hepatitis B
Robert J. Fontana
HEPATOLOGY (2009)
Conversion from a Calcineurin Inhibitor to Everolimus Therapy in Maintenance Liver Transplant Recipients: A Prospective, Randomized, Multicenter Trial
Paolo De Simone et al.
LIVER TRANSPLANTATION (2009)
Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT)
Richard Ruiz et al.
LIVER TRANSPLANTATION (2007)
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation
Edward J. Gane et al.
GASTROENTEROLOGY (2007)
Pharmacokinetics and safety of a novel anti-HBs-enriched immunoglobulin in healthy volunteers after subcutaneous and intramuscular administration
Petra A. Thuermann et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels
I Morard et al.
CLINICAL TRANSPLANTATION (2006)
Chronic renal failure after transplantation of a nonrenal organ
AO Ojo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation
D Faust et al.
CLINICAL TRANSPLANTATION (2003)
Share Paper
